NASDAQ NMS - GLOBAL MARKET · AQST
+0.86% · +$0.0400 · Vol Not reported
Pre-market · updated 04:00:00 ET
Aquestive Therapeutics Inc

Aquestive Therapeutics Inc

Pharmaceuticals
$4.70
Card
Relationship Map

Veridion Score

BETALOW CONF · 5/6 factorsMethodology
Sentiment absence reason unknown
AQST
Aquestive Therapeutics Inc
Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

53/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 5/6 factors with data · Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is AQST moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading AQST catalysts
About Aquestive Therapeutics Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2018
Employees
147
Country
US

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$4.66
Last session
Day high
$4.66
Last session
Day low
$4.66
Last session
Previous close
$4.66
52W high
$7.49
-37.25% from high
52W low
$2.95
39% of range
Market cap
$584.9M
EPS
$-0.5300
Beta
0.83
Shares out
125.5M
Avg volume
3.1M
VWAP
$4.66
Last session
Price history computed in-house
1W
+9.56%
1M
+27.72%
3M
+15.20%
1Y
+18.09%
YTD
-27.24%
SMA 50 $4.17 · above
SMA 200 $4.49 · above
52W position 39%

AQST overview

Veridion Score
53
Registered · 2026-08-21
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around AQST.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading AQST Form 4 filings
Public disclosures

Congress activity in AQST

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for AQST in the cached public ledger.

Federal contracts

AQST contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for AQST in this window.
Lobbying spend

AQST lobbying filings, year to date.

Registered lobbying filings matched to Aquestive Therapeutics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for AQST in this window.
Loading news for AQST
Analyst ratings
Sovereign unlock shows live analyst consensus for AQST.
Options
Sovereign unlock shows live options positioning for AQST.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.